Cargando…
Are estrogen-related drugs new alternatives for the management of osteoarthritis?
Osteoarthritis (OA) is a chronic degenerative disease involving multiple physiopathological mechanisms. The increased prevalence of OA after menopause and the presence of estrogen receptors in joint tissues suggest that estrogen could help prevent development of OA. This review summarizes OA researc...
Autores principales: | Xiao, Ya-Ping, Tian, Fa-Ming, Dai, Mu-Wei, Wang, Wen-Ya, Shao, Li-Tao, Zhang, Liu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924302/ https://www.ncbi.nlm.nih.gov/pubmed/27352621 http://dx.doi.org/10.1186/s13075-016-1045-7 |
Ejemplares similares
-
Strontium ranelate causes osteophytes overgrowth in a model of early phase osteoarthritis
por: Chu, Jian-Guo, et al.
Publicado: (2017) -
Complementary and Alternative Exercises for Management of Osteoarthritis
por: Chyu, Ming-Chien, et al.
Publicado: (2011) -
Estrogen-related receptors: novel potential regulators of osteoarthritis pathogenesis
por: Tang, Jinshuo, et al.
Publicado: (2021) -
Osteoarthritis associated with estrogen deficiency
por: Roman-Blas, Jorge A, et al.
Publicado: (2009) -
Raloxifene inhibits the overexpression of TGF-β1 in cartilage and regulates the metabolism of subchondral bone in rats with osteoporotic osteoarthritis
por: Ping, Shao-Hua, et al.
Publicado: (2021)